Stem cells for therapy can be sourced from various origins:
Autologous stem cells: These are derived from the patient's own body, reducing the risk of immune rejection. Allogeneic stem cells: These are sourced from a donor, which may carry a risk of immune rejection but are sometimes necessary when autologous cells are not available. Induced pluripotent stem cells (iPSCs): These are adult cells genetically reprogrammed to an embryonic stem cell-like state, offering a potential source for patient-specific therapies.
